Chemoinformaics analysis of Lavandulyl isobutanoate
| Molecular Weight | 222.372 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 222.198 | nRing | 3 |
| Solubility: LogS | -3.596 | nHRing | 0 |
| Solubility: LogP | 3.87 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 43.1886 |
| nHD | 1 | BPOL | 26.0834 |
| QED | 0.664 |
| Synth | 5.662 |
| Natural Product Likeliness | 2.852 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.767 |
| MDCK | 0.0000205 |
| BBB | 0.786 |
| PPB | 0.909942 |
| VDSS | 1.14 |
| FU | 0.12214 |
| CYP1A2-inh | 0.071 |
| CYP1A2-sub | 0.46 |
| CYP2c19-inh | 0.103 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.216 |
| CYP2c9-sub | 0.258 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.622 |
| CYP3a4-inh | 0.397 |
| CYP3a4-sub | 0.222 |
| CL | 10.356 |
| T12 | 0.142 |
| hERG | 0.014 |
| Ames | 0.013 |
| ROA | 0.208 |
| SkinSen | 0.068 |
| Carcinogencity | 0.021 |
| EI | 0.653 |
| Respiratory | 0.954 |
| NR-Aromatase | 0.056 |
| Antiviral | Yes |
| Prediction | 0.835437 |